|
JP2000516231A
(ja)
|
1996-08-09 |
2000-12-05 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
免疫調節物質としての４―置換β―カルボリン
|
|
AU751139B2
(en)
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
CA2327185A1
(en)
|
1998-04-08 |
1999-10-14 |
Abbott Laboratories |
Pyrazole inhibitors of cytokine production
|
|
US6506747B1
(en)
|
1998-06-05 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
|
|
US20010044445A1
(en)
|
1999-04-08 |
2001-11-22 |
Bamaung Nwe Y. |
Azole inhibitors of cytokine production
|
|
CA2376275A1
(en)
|
1999-08-20 |
2001-03-01 |
Michael John Ricks |
Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
|
|
JP3910319B2
(ja)
|
1999-09-13 |
2007-04-25 |
株式会社小糸製作所 |
自動車用灯具
|
|
EP1143013A1
(en)
|
2000-04-03 |
2001-10-10 |
Warner-Lambert Company |
Methods and compositions for screening Icrac modulators
|
|
CA2445712A1
(en)
*
|
2001-05-31 |
2002-12-05 |
Cellegy Pharmaceuticals, Inc. |
Store operated calcium influx inhibitors and methods of use
|
|
GB0225554D0
(en)
|
2002-11-01 |
2002-12-11 |
Syngenta Participations Ag |
Chemical compounds
|
|
WO2004054977A1
(en)
|
2002-12-13 |
2004-07-01 |
Cytopia Pty Ltd |
Nicotinamide-based kinase inhibitors
|
|
JP4896518B2
(ja)
|
2002-12-13 |
2012-03-14 |
ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド |
ニコチンアミド系キナーゼ阻害薬
|
|
US20060100245A1
(en)
|
2002-12-19 |
2006-05-11 |
Neurogen Corporation |
Substituted biphenyl-4-carboxylic acid arylamide analogues
|
|
WO2004078995A2
(en)
|
2003-03-04 |
2004-09-16 |
Neurogenetics, Inc. |
Methods of modulating and of identifying agents that modulate intracellular calcium
|
|
NZ545447A
(en)
|
2003-07-23 |
2010-03-26 |
Synta Pharmaceuticals Corp |
Compounds for inflammation and immune-related uses
|
|
AR046959A1
(es)
|
2003-12-18 |
2006-01-04 |
Tibotec Pharm Ltd |
Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
|
|
DE102004005785A1
(de)
|
2004-02-06 |
2005-08-25 |
Bayer Cropscience Ag |
2-Halogenfuryl/thienyl-3-carboxamide
|
|
WO2006006569A1
(ja)
|
2004-07-12 |
2006-01-19 |
Nihon Nohyaku Co., Ltd. |
フェニルピリジン類又はその塩類、これらを有効成分とする除草剤及びその使用方法
|
|
KR20070057965A
(ko)
|
2004-09-21 |
2007-06-07 |
신타 파마슈티칼스 코프. |
염증 및 면역 관련 용도를 위한 화합물
|
|
US8557861B2
(en)
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
|
WO2006083477A2
(en)
|
2005-01-07 |
2006-08-10 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
AU2006208045B2
(en)
|
2005-01-25 |
2012-08-30 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
WO2006081389A1
(en)
|
2005-01-25 |
2006-08-03 |
Synta Pharmaceuticals Corp. |
Thiophene compounds for inflammation and immune-related uses
|
|
NZ560712A
(en)
|
2005-02-17 |
2010-12-24 |
Synta Pharmaceuticals Corp |
(3,4,5-trisubstituted-phenyl)isoxazole combretastin derivatives for the treatment of disorders
|
|
EP1879881A2
(en)
|
2005-04-14 |
2008-01-23 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
|
EP1937270A1
(en)
|
2005-09-21 |
2008-07-02 |
Brystol-Myers Squibb Company |
Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
|
|
NL2000284C2
(nl)
|
2005-11-04 |
2007-09-28 |
Pfizer Ltd |
Pyrazine-derivaten.
|
|
PT2404919E
(pt)
|
2005-11-08 |
2013-10-22 |
Vertex Pharma |
Composto heterocíclico útil como um modulador de transportadores de cassete de ligação a atp
|
|
AU2006315177A1
(en)
|
2005-11-15 |
2007-05-24 |
Baxter Healthcare S.A. |
Compositions of lipoxygenase inhibitors
|
|
EP1984400B1
(en)
|
2006-01-05 |
2012-11-28 |
Immune Disease Institute, Inc. |
Regulators of nfat
|
|
CA2639913A1
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceutical Corp. |
Phenyl and pyridyl compounds for inflammation and immune-related uses
|
|
WO2007087443A2
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Vinyl-phenyl derivatives for inflammation and immune-related uses
|
|
JP2009528273A
(ja)
|
2006-01-25 |
2009-08-06 |
シンタ ファーマシューティカルズ コーポレーション |
炎症および免疫関連使用用の置換ビアリール化合物
|
|
JP2009524677A
(ja)
|
2006-01-25 |
2009-07-02 |
シンタ ファーマシューティカルズ コーポレーション |
炎症および免疫関連使用用のチアゾールおよびチアジアゾール化合物
|
|
CA2640090A1
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
AU2007211276B2
(en)
|
2006-01-31 |
2013-06-06 |
Synta Pharmaceuticals Corp. |
Pyridylphenyl compounds for inflammation and immune-related uses
|
|
US7951824B2
(en)
|
2006-02-17 |
2011-05-31 |
Hoffman-La Roche Inc. |
4-aryl-pyridine-2-carboxyamide derivatives
|
|
CA2645434A1
(en)
|
2006-03-20 |
2007-09-27 |
Synta Pharmaceutical Corp. |
Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
|
|
AU2007230911A1
(en)
|
2006-03-23 |
2007-10-04 |
Synta Pharmaceuticals Corp. |
Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
|
|
EP2004627A2
(en)
|
2006-04-10 |
2008-12-24 |
Arena Pharmaceuticals, Inc. |
3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
NZ623002A
(en)
|
2006-06-26 |
2015-08-28 |
Akebia Therapeutics Inc |
Prolyl hydroxylase inhibitors and methods of use
|
|
EP2086326B1
(en)
|
2006-11-13 |
2014-01-08 |
Synta Pharmaceuticals Corp. |
Cyclohexenyl-aryl compounds for inflammation and immune-related uses
|
|
EP2129219A4
(en)
|
2007-02-16 |
2012-08-29 |
Synta Pharmaceuticals Corp |
SUBSTITUTED FUSED CYCLE COMPOUNDS USED IN CASES OF INFLAMMATION OR IMMUNE DISORDERS
|
|
CA2680106A1
(en)
|
2007-03-23 |
2008-10-02 |
H. William Bosch |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods for making the same
|
|
CA2688417C
(en)
|
2007-05-24 |
2017-04-25 |
Calcimedica, Inc. |
Calcium channel proteins and uses thereof
|
|
EP2185514A4
(en)
|
2007-08-01 |
2011-05-18 |
Synta Pharmaceuticals Corp |
VINYL-ARYL DERIVATIVES FOR INFLAMMATORY AND IMMUNE DISORDERS
|
|
ES2440267T3
(es)
|
2007-08-01 |
2014-01-28 |
Synta Pharmaceuticals Corporation |
Compuestos de heterociclo-arilo para la inflamación y usos inmunorrelacionados
|
|
CA2695621A1
(en)
|
2007-08-09 |
2009-02-12 |
Merck Sharp & Dohme Corp. |
Pyridine carboxamide orexin receptor antagonists
|
|
RU2465272C2
(ru)
|
2007-09-10 |
2012-10-27 |
КалсиМедика, Инк. |
Соединения, моделирующие внутриклеточный кальций
|
|
US20110052643A1
(en)
|
2008-01-07 |
2011-03-03 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
FR2927330B1
(fr)
|
2008-02-07 |
2010-02-19 |
Sanofi Aventis |
Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii
|
|
US20110003859A1
(en)
|
2008-02-29 |
2011-01-06 |
Array Biopharma Inc. |
N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
|
|
US20110305709A1
(en)
|
2008-03-20 |
2011-12-15 |
Attila Braun |
Calcium sensor stim1 and the platelet soc channel orai1 (cracm1) are essential for pathological thrombus formation
|
|
US20100016598A1
(en)
|
2008-07-16 |
2010-01-21 |
Wyeth |
Alpha7 nicotinic acetylcholine receptor inhibitors
|
|
CA2734500A1
(en)
|
2008-08-27 |
2010-03-11 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
|
US20110269743A1
(en)
|
2008-09-22 |
2011-11-03 |
CalciMedica, Inc |
Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
|
|
US8524763B2
(en)
|
2008-09-22 |
2013-09-03 |
Calcimedica, Inc. |
Inhibitors of store operated calcium release
|
|
AU2009300318A1
(en)
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
EP2350064A1
(en)
|
2008-10-01 |
2011-08-03 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
WO2010048559A2
(en)
|
2008-10-24 |
2010-04-29 |
Calcimedica Inc. |
Phenylpyrazole inhibitors of store operated calcium release
|
|
US8399436B2
(en)
|
2009-04-24 |
2013-03-19 |
Glaxo Group Limited |
N-pyrazolyl carboxamides as CRAC channel inhibitors
|
|
WO2010122088A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
JP6072539B2
(ja)
|
2009-05-27 |
2017-02-01 |
アルカーメス ファーマ アイルランド リミテッド |
ナノ粒子活性物質組成物におけるフレーク状凝集の軽減
|
|
US8618307B2
(en)
|
2009-09-16 |
2013-12-31 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US8993612B2
(en)
|
2009-10-08 |
2015-03-31 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
|
|
US8377970B2
(en)
|
2009-10-08 |
2013-02-19 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel
|
|
AU2010321832B2
(en)
|
2009-11-20 |
2014-08-14 |
Amgen Inc. |
Anti-Orai1 antigen binding proteins and uses thereof
|
|
US8476006B2
(en)
|
2009-11-30 |
2013-07-02 |
National Center For Biological Sciences |
Store-operated calcium cellular assay
|
|
EP2531490B1
(en)
|
2010-02-02 |
2014-10-15 |
Novartis AG |
Cyclohexyl amide derivatives as crf receptor antagonists
|
|
JP6112486B2
(ja)
|
2010-04-27 |
2017-04-12 |
カルシメディカ，インク． |
細胞内カルシウムを調節する化合物
|
|
US10703722B2
(en)
|
2010-04-27 |
2020-07-07 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
EP2563759B1
(en)
|
2010-04-27 |
2022-04-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
CN103180316A
(zh)
|
2010-08-27 |
2013-06-26 |
钙医学公司 |
调节细胞内钙的化合物
|
|
EP2704701B1
(en)
|
2011-05-03 |
2018-01-03 |
PRCL Research Inc. |
Compounds for inflammation and immune-related uses
|
|
WO2012170931A2
(en)
|
2011-06-10 |
2012-12-13 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US20130143927A1
(en)
|
2011-06-10 |
2013-06-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
JP2014523911A
(ja)
|
2011-07-21 |
2014-09-18 |
黒▲龍▼江宝▲慶▼隆生物技▲術▼有限責任公司 |
イブプロフェン系化合物、その調製方法、使用および製剤
|
|
EP2768810A1
(en)
|
2011-10-19 |
2014-08-27 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2013059677A1
(en)
|
2011-10-19 |
2013-04-25 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
JP5936350B2
(ja)
|
2011-12-27 |
2016-06-22 |
キヤノン株式会社 |
新規有機化合物
|
|
EP2844655A1
(en)
|
2012-05-02 |
2015-03-11 |
Lupin Limited |
Substituted pyridine compounds as crac modulators
|
|
WO2014043715A1
(en)
|
2012-09-17 |
2014-03-20 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US9725463B2
(en)
|
2013-06-21 |
2017-08-08 |
Lupin Limited |
Substituted heterocyclic compounds as CRAC modulators
|
|
TWI771269B
(zh)
|
2015-02-27 |
2022-07-21 |
美商鈣系醫藥公司 |
胰腺炎治療
|
|
CA2995094A1
(en)
|
2015-08-07 |
2017-02-16 |
Calcimedica, Inc. |
Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
|
|
US20200253966A1
(en)
|
2017-01-26 |
2020-08-13 |
Calcimedica, Inc. |
Crac channel inhibitor compositions
|
|
JP2022508468A
(ja)
|
2018-09-14 |
2022-01-19 |
ルヒゼン ファーマスティカルズ アクツィエンゲゼルシャフト |
Ｃｒａｃ阻害剤およびコルチコステロイドを含む組成物ならびにそれらの使用方法
|
|
US20210338630A1
(en)
|
2018-10-04 |
2021-11-04 |
The Trustees Of Indiana University |
Methods to treat renal disorders using calcium channel inhibitors
|
|
WO2020227312A1
(en)
|
2019-05-06 |
2020-11-12 |
Calcimedica, Inc. |
Synthesis of crac channel inhibitors
|
|
CA3172249A1
(en)
|
2020-03-20 |
2021-09-23 |
Calcimedica, Inc. |
Methods and compositions for treating acute lung injury and acute respiratory distress syndrome
|
|
CN116261468A
(zh)
|
2020-05-20 |
2023-06-13 |
钙医学公司 |
治疗急性肾损伤的方法和组合物
|
|
JP7791898B2
(ja)
|
2020-11-13 |
2025-12-24 |
カルシメディカ，インク． |
Ｃｒａｃチャネル阻害剤の合成の改善
|